Insider filing · NUVL
Christopher Durant Turner
Chief Medical Officer
profile →
Nuvalent Inc
NUVL · Healthcare · 86 filings in 24 months
ticker →
Christopher Durant Turner sold $584K of Nuvalent (NUVL)
Executed Jan 5, disclosed Jan 7, 2 days later.
Value, as filed
$584K
6,004 sh across 4 lots
Executed
Jan 5
the trade date, as filed
Disclosed
Jan 7
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CTChristopher Durant Turner (Chief Medical Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Nuvalent Inc (NUVL). The largest single filing was $584K of NUVL (6,004 sh across 4 lots, as filed), executed Jan 5.
The name
NUVLHealthcare · Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Christopher Durant Turner in NUVL
NUVLSALE
Nuvalent Inc
$175K2,173 sh × $80.54
Exec Jan 6 2025
Filed Jan 8 2025 · 5:30 PM ET